Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Policy & Regulation
Trends & Finance
Trends and Finance: Page 2
Agilent Technologies, Proscia ink digital pathology distribution agreement
Combining Agilent's pathology staining solutions with Proscia’s Concentriq Dx enterprise pathology platform will empower pathology labs to transform diagnostic efficiency and quality, Agilent said.
March 8, 2023
Fujifilm Healthcare Americas entering digital pathology, features newly branded solution at USCAP 2023
Fujifilm's solution delivers digital images for diagnosis 1.7 hours faster than glass slides, and facilitates instant sharing of patient cases with subspecialists, allowing for speedier diagnosis and treatment of patients, the firm said.
March 10, 2023
FDA grants clearance to Abbott for first commercial laboratory test to detect traumatic brain injury
The test runs on Abbott's Alinity i laboratory immunoassay instrument, providing a result in 18 minutes to help clinicians quickly assess concussion and triage patients, Abbott said. Negative results rule out the need for a CT scan.
March 7, 2023
Quanterix Q4 revenues drop 15% but match analysts’ expectations
For full-year 2022, total revenue was $105.5 million, a decline of 5% compared with 2021 revenue that included $5.2 million in National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) grant money.
March 6, 2023
Myriad Genetics Q4 revenues rise 11% on strength in hereditary cancer, pharmacogenomics testing
Revenue for the quarter ended December 31 was driven by 16% growth in hereditary cancer testing volumes and 23% growth in volumes for the GeneSight pharmacogenomics test.
March 1, 2023
Pathology services provider PathGroup adopts Proscia digital platform
PathGroup supports more than 15,000 referring physicians and more than 200 hospital customers with diversified laboratory testing services and customer service.
March 1, 2023
Most Popular
Genetic causes identified for three rare diseases
Researchers in study validate test to identify newborns with homocystinuria, a rare inherited disease
FDA reissues EUA for Janssen COVID-19 vaccine, includes warning about risks of myocarditis, pericarditis
Duke University researchers discover biomarkers may identify early pancreatic cancer risk
Netherlands researchers combine CRISPR, bioluminescence in proof-of-concept infectious disease test
Werfen completes $2B acquisition of Immucor, expands presence in specialized diagnostics
Agilent Technologies Q1 revenues rise 5% on strength in life sciences, applied markets
February 28, 2023
Cardio Diagnostics launches AI-based blood test for the early detection of coronary heart disease
PrecisionCHD is an integrated epigenetic-genetic blood test that uses machine learning for the early detection of coronary heart disease.
February 28, 2023
NanoSpot.ai launches AI-based SARS-CoV-2 antibody test
The test uses an agglutination-based method combined with an artificial intelligence (AI)-enabled mobile application to deliver semi-quantitative antibody test results at the point of care.
February 28, 2023
Roche, CDC expand partnership on HIV and TB support for healthcare systems in critical regions
The public-private partnership, named Lab Networks for Health, aims to improve HIV and TB detection, prevention, and treatment in countries that have been hit hardest by the two diseases.
February 28, 2023
Lucira Health files for bankruptcy despite receiving FDA green light
The firm is seeking a strategic or financial partner for the resumption of manufacturing and development of additional home diagnostic testing products.
February 27, 2023
Opko Health Q4 revenues drop 54% as BioReference business reduces costs
BioReference processed approximately 100,000 COVID-19 PCR tests in the fourth quarter of 2022 compared with 2.7 million tests in the fourth quarter of 2021.
February 24, 2023
Previous Page
Page 2 of 113
Next Page